Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Phase I study of aplidine as a three-hour infusion in solid tumor patients

June 3, 2002

Survival benefit for long-term atrasentan in HRPCa

June 3, 2002

Antitumor xanthone compounds obtained from Streptomyces

June 3, 2002

New prenyltransferase inhibitors in early development at Merck

June 3, 2002

MLN-518 enters phase I in AML

May 31, 2002

Single-dose palonosetron provides prolonged relief from CINV

May 31, 2002

LymphoRad targets B-cells and B-cell tumors and exerts antitumor activity in preclinical studies

May 31, 2002

Phase I results support further development of ABX-EGF for cancer

May 31, 2002

Potent inhibitor of Jak family protein tyrosine kinases discovered at Merck

May 31, 2002

Early clinical data for DRF-1042 presented at ASCO

May 31, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 15, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 15, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...